Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA
11019
Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)

Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)